Ignite Creation Date:
2025-12-24 @ 12:44 PM
Ignite Modification Date:
2026-02-12 @ 3:29 AM
Study NCT ID:
NCT01589861
Status:
SUSPENDED
Last Update Posted:
2017-03-28
First Post:
2012-03-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer
Sponsor:
Institut Paoli-Calmettes
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2018-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-01
Completion Date Type:
ESTIMATED
First Submit Date:
2012-03-28
First Submit QC Date:
None
Study First Post Date:
2012-05-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-27
Last Update Post Date:
2017-03-28
Last Update Post Date Type:
ACTUAL